|Layman’s summary:||There is the potential for a blood screening for kidney disease.|
|Publication date:||July 2011|
|Published in:||Nature Medicine|
|Lead author:||Changli Wei|
|Department of Medicine, Miller School of Medicine
University of Miami
Abstract: Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease, compromising both native and transplanted kidneys. Treatment is limited because of a complex pathogenesis, including unknown serum factors. Here we report that serum soluble urokinase receptor (suPAR) is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases.